Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-172894

Xenbase Image ID: 172894


Fig. S3. SMAD1 inhibition during cardiac chamber differentiation does not affect expression of the cardiac markers tropomyosin and Tbx5. (A,B) In situ hybridization for Tbx5 on stage 40 DMSO (A) and dorsomorphin-treated (B) anterior explants shows normal expression of Tbx5 in the heart and cardinal vein after SMAD1 inhibition. (C-F) Whole-mount antibody staining for tropomyosin of a stage 40 DMSO (C,E) or dorsomorphin-treated (D,F) anterior explants. Ventral view reveals no change in expression of tropomyosin in the heart after treatment with dorsomorphin. Dorso, dorsomorphin. Scale bars: 1 mm.

Image published in: Mandel EM et al. (2010)

Copyright © 2010. Image reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.

GeneSynonymsSpeciesStage(s)Tissue
tbx5.Ltbx-5, tbx5-a, tbx5-b, xtbx-5, xtbx5X. laevisThroughout NF stage 40heart
cardinal vein
tpm1.Lalpha-tm, alpha-tropomyosin, CH1X. laevisThroughout NF stage 40heart

Image source: Published

Larger Image
Printer Friendly View

Return to previous page